GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals
about
Pharmacogenomics of hypertension and heart diseasePharmacogenomics of statins: understanding susceptibility to adverse effectsPatients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challengeThe adjuvant value of Herba Cistanches when used in combination with statin in murine models.Statins, Muscle Disease and Mitochondria.Institutional profile of pharmacogenetics within University of Michigan College of Pharmacy.
P2860
GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
GATM polymorphism associated w ...... f 715 dyslipidemic individuals
@en
GATM polymorphism associated w ...... 715 dyslipidemic individuals.
@nl
type
label
GATM polymorphism associated w ...... f 715 dyslipidemic individuals
@en
GATM polymorphism associated w ...... 715 dyslipidemic individuals.
@nl
prefLabel
GATM polymorphism associated w ...... f 715 dyslipidemic individuals
@en
GATM polymorphism associated w ...... 715 dyslipidemic individuals.
@nl
P2093
P2860
P1433
P1476
GATM polymorphism associated w ...... f 715 dyslipidemic individuals
@en
P2093
Anees M Dauki
Changxing Ma
Eduard B Mikulik
Georgirene D Vladutiu
Jasmine A Luzum
Joseph P Kitzmiller
Marisa W Medina
Paul J Isackson
P2860
P304
P356
10.1016/J.CMET.2015.03.003
P577
2015-04-01T00:00:00Z